High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19
•Infectious SARS-CoV-2 remained in 55% (6/11) corpses and 43% (13/30) specimens.•The highest infectious titer was 2.09E + 06 plaque-forming units/g in corpse lung tissue.•The time from death to discovery was 0-1 day in all cases with the infectious virus.•The longest postmortem interval with virus i...
Saved in:
Published in | International journal of infectious diseases Vol. 129; pp. 103 - 109 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Canada
Elsevier Ltd
01.04.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •Infectious SARS-CoV-2 remained in 55% (6/11) corpses and 43% (13/30) specimens.•The highest infectious titer was 2.09E + 06 plaque-forming units/g in corpse lung tissue.•The time from death to discovery was 0-1 day in all cases with the infectious virus.•The longest postmortem interval with virus infectivity was 13 days (12 days refrigerated).•The status of the corpse influences SARS-CoV-2 infectivity.
The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19.
We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation.
Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days.
The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses. |
---|---|
AbstractList | Objectives: The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19. Methods: We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation. Results: Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days. Conclusion: The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses. •Infectious SARS-CoV-2 remained in 55% (6/11) corpses and 43% (13/30) specimens.•The highest infectious titer was 2.09E + 06 plaque-forming units/g in corpse lung tissue.•The time from death to discovery was 0-1 day in all cases with the infectious virus.•The longest postmortem interval with virus infectivity was 13 days (12 days refrigerated).•The status of the corpse influences SARS-CoV-2 infectivity. The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19. We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation. Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days. The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses. The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19.OBJECTIVESThe prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19.We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation.METHODSWe collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation.Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days.RESULTSInfectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days.The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses.CONCLUSIONThe corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses. The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been determined. Such information is important for public health, death investigation, and handling corpses. The aim of this study was to assess the level of SARS-CoV-2 infectivity in the corpses of patients with COVID-19. We collected 11 nasopharyngeal swabs and 19 lung tissue specimens from 11 autopsy cases with COVID-19 in 2021. We then investigated the viral genomic copy number by real-time reverse transcription-polymerase chain reaction and infectious titers by cell culture and virus isolation. Infectious virus was present in six of 11 (55%) cases, four of 11 (36%) nasopharyngeal swabs, and nine of 19 (47%) lung specimens. The virus titers ranged from 6.00E + 01 plaque-forming units/ml to 2.09E + 06 plaque-forming units/g. In all cases in which an infectious virus was found, the time from death to discovery was within 1 day and the longest postmortem interval was 13 days. The corpses of patients with COVID-19 may have high titers of infectious virus after a long postmortem interval (up to 13 days). Therefore, appropriate infection control measures must be taken when handling corpses. |
Author | Iwase, Hirotaro Rokutan, Hirofumi Chiba, Fumiko Kubota, Kazumi Katano, Harutaka Inokuchi, Go Hoshioka, Yumi Okaba, Keisuke Iida, Shun Ushiku, Tetsuo Tsuneya, Shigeki Hirata, Yuichiro Yamamoto, Isao Hasegawa, Iwao Makino, Yohsuke Hinata, Munetoshi Yamaguchi, Rutsuko Abe, Hiroyuki Kira, Kei Iwasaki, Akiko Yasunaga, Yoichi Suzuki, Tadaki Nakajima, Makoto Mori, Aika Ishii, Namiko Iwatsuki-Horimoto, Kiyoko Horioka, Kie Nagasawa, Sayaka Akitomi, Shinji Nakagawa, Kimiko Yajima, Daisuke Kawaoka, Yoshihiro Motomura, Ayumi Sakai-Tagawa, Yuko Kobayashi, Susumu Ikemura, Masako Torimitsu, Suguru Saitoh, Hisako |
Author_xml | – sequence: 1 givenname: Hisako orcidid: 0000-0001-6297-3738 surname: Saitoh fullname: Saitoh, Hisako email: hms1466@faculty.chiba-u.jp organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 2 givenname: Yuko surname: Sakai-Tagawa fullname: Sakai-Tagawa, Yuko organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan – sequence: 3 givenname: Sayaka surname: Nagasawa fullname: Nagasawa, Sayaka organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 4 givenname: Suguru orcidid: 0000-0003-4891-8673 surname: Torimitsu fullname: Torimitsu, Suguru organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 5 givenname: Kazumi orcidid: 0000-0003-2270-2313 surname: Kubota fullname: Kubota, Kazumi organization: Department of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan – sequence: 6 givenname: Yuichiro surname: Hirata fullname: Hirata, Yuichiro organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 7 givenname: Kiyoko surname: Iwatsuki-Horimoto fullname: Iwatsuki-Horimoto, Kiyoko organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan – sequence: 8 givenname: Ayumi surname: Motomura fullname: Motomura, Ayumi organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 9 givenname: Namiko surname: Ishii fullname: Ishii, Namiko organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 10 givenname: Keisuke surname: Okaba fullname: Okaba, Keisuke organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 11 givenname: Kie surname: Horioka fullname: Horioka, Kie organization: Department of Legal Medicine, International University of Health and Welfare, Tokyo, Japan – sequence: 12 givenname: Hiroyuki orcidid: 0000-0003-4513-1007 surname: Abe fullname: Abe, Hiroyuki organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 13 givenname: Masako surname: Ikemura fullname: Ikemura, Masako organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 14 givenname: Hirofumi orcidid: 0000-0003-4172-4892 surname: Rokutan fullname: Rokutan, Hirofumi organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 15 givenname: Munetoshi surname: Hinata fullname: Hinata, Munetoshi organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 16 givenname: Akiko surname: Iwasaki fullname: Iwasaki, Akiko organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 17 givenname: Yoichi surname: Yasunaga fullname: Yasunaga, Yoichi organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 18 givenname: Makoto surname: Nakajima fullname: Nakajima, Makoto organization: Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 19 givenname: Rutsuko surname: Yamaguchi fullname: Yamaguchi, Rutsuko organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 20 givenname: Shigeki surname: Tsuneya fullname: Tsuneya, Shigeki organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 21 givenname: Kei orcidid: 0000-0002-9250-8420 surname: Kira fullname: Kira, Kei organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 22 givenname: Susumu surname: Kobayashi fullname: Kobayashi, Susumu organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 23 givenname: Go surname: Inokuchi fullname: Inokuchi, Go organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 24 givenname: Fumiko orcidid: 0000-0001-5636-0695 surname: Chiba fullname: Chiba, Fumiko organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 25 givenname: Yumi orcidid: 0000-0001-8852-6530 surname: Hoshioka fullname: Hoshioka, Yumi organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 26 givenname: Aika surname: Mori fullname: Mori, Aika organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 27 givenname: Isao surname: Yamamoto fullname: Yamamoto, Isao organization: Department of Forensic Medicine, Kanagawa Dental University, Yokosuka, Japan – sequence: 28 givenname: Kimiko surname: Nakagawa fullname: Nakagawa, Kimiko organization: Department of Forensic Medicine, Kanagawa Dental University, Yokosuka, Japan – sequence: 29 givenname: Harutaka orcidid: 0000-0002-5332-4434 surname: Katano fullname: Katano, Harutaka organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 30 givenname: Shun orcidid: 0000-0003-2258-9031 surname: Iida fullname: Iida, Shun organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 31 givenname: Tadaki surname: Suzuki fullname: Suzuki, Tadaki organization: Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 32 givenname: Shinji surname: Akitomi fullname: Akitomi, Shinji organization: Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 33 givenname: Iwao surname: Hasegawa fullname: Hasegawa, Iwao organization: Department of Forensic Medicine, Kanagawa Dental University, Yokosuka, Japan – sequence: 34 givenname: Tetsuo surname: Ushiku fullname: Ushiku, Tetsuo organization: Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 35 givenname: Daisuke surname: Yajima fullname: Yajima, Daisuke organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 36 givenname: Hirotaro surname: Iwase fullname: Iwase, Hirotaro organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 37 givenname: Yohsuke orcidid: 0000-0002-0025-5252 surname: Makino fullname: Makino, Yohsuke organization: Department of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan – sequence: 38 givenname: Yoshihiro surname: Kawaoka fullname: Kawaoka, Yoshihiro organization: Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36754229$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1vVCEYhYmpsR_6B1yYu3Rzr8D9AIybZqp2kiZNrHZLmJeXluudywiMpv9eptO66KKuIOQ8h-Q8x-RgDjMS8pbRhlE2fBgbP3rbcMrbhrKGdsMLcsSkkHXbM3ZQ7pyyWgnGD8lxSiOlJTLIV-SwHUTfca6OyPLc39xW2WeMqQqu8rNDyD5sU3V1-u2qXoTrmpfXCkLcJLzPbEz2OOdU_fH5tlpcXi_PaqZek5fOTAnfPJwn5MeXz98X5_XF5dfl4vSihp6JXNtBCKXAYE8d66ik3FrXrwQHULRVTqiBcVDKdtQNwjgqOQyrHiwD2inXtydkue-1wYx6E_3axDsdjNf3DyHeaBOzhwk1mrblCFxyjl0rwYAD20uAzsleuLZ0vd93bWL4tcWU9donwGkyM5YJNBeik2oYmCzRdw_R7WqN9t_Hj1OWgNwHIIaUIjoNPpelwpyj8ZNmVO-s6VHvrOmdNU2ZLkoKyp-gj-3PQp_2EJaxf3uMOkHRAmh9LArLGv55_OMTHCY_ezDTT7z7H_wXc83A_g |
CitedBy_id | crossref_primary_10_3390_forensicsci4040042 crossref_primary_10_3390_forensicsci5010006 crossref_primary_10_1371_journal_pone_0287068 crossref_primary_10_1002_ase_2501 crossref_primary_10_1016_j_legalmed_2024_102530 |
Cites_doi | 10.1007/s12024-021-00379-9 10.1128/JCM.01094-20 10.3201/eid2701.203112 10.3201/eid2706.210226 10.3201/eid2801.211749 10.1038/s41598-021-98499-3 10.1016/j.jflm.2020.101999 10.1097/PAF.0000000000000779 10.1016/j.ijid.2021.03.052 10.7883/yoken.JJID.2020.061 10.1136/bmjgh-2020-002650 10.1007/s00414-021-02546-7 10.1007/s12024-021-00375-z 10.3201/eid2609.201353 10.4103/jfsm.jfsm_5_21 10.1002/jmv.21962 10.1073/pnas.2002589117 10.1007/s00414-021-02753-2 10.7554/eLife.60361 |
ContentType | Journal Article |
Copyright | 2023 The Author(s) Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
Copyright_xml | – notice: 2023 The Author(s) – notice: Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
DOI | 10.1016/j.ijid.2023.01.046 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ: Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1878-3511 |
EndPage | 109 |
ExternalDocumentID | oai_doaj_org_article_ea332ec2822e438cacfcd58cc4f857f3 36754229 10_1016_j_ijid_2023_01_046 S1201971223000474 |
Genre | Journal Article |
GroupedDBID | --- --K .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29J 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 7X7 88E 8C1 8FI 8FJ 8FQ 8R4 8R5 AAEDW AAFWJ AAIKJ AALRI AAQFI AAQXK AARKO AAXUO AAYWO ABBQC ABFRF ABMAC ABUWG ABWVN ACGFO ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFJKZ AFKRA AFPKN AFPUW AFRHN AFTJW AGEKW AGHFR AGQPQ AGYEJ AHMBA AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BAWUL BCNDV BENPR BPHCQ BR6 BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU FYUFA G-Q GBLVA GROUPED_DOAJ GX1 HMCUK HVGLF HZ~ IHE IXB J1W KQ8 M1P M3C M3G M41 MO0 N9A O-L O9- OD- OK1 OO. OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q2X Q38 QTD R2- ROL RPZ RWL RXW SDF SDG SEL SES SEW SSZ TAE UKHRP UNMZH Z5R 0SF 3V. 6I. AACTN AAFTH ABVKL AFCTW ALIPV NCXOZ RIG AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c517t-d67799cae50f140802ddf5b72cc9039f79612c99d40f67af082c6b5cd1c049f53 |
IEDL.DBID | .~1 |
ISSN | 1201-9712 1878-3511 |
IngestDate | Wed Aug 27 01:21:13 EDT 2025 Fri Jul 11 09:01:16 EDT 2025 Wed Feb 19 02:25:00 EST 2025 Tue Jul 01 04:30:16 EDT 2025 Thu Apr 24 23:13:24 EDT 2025 Tue Jun 18 08:52:08 EDT 2024 Tue Aug 26 16:32:02 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | COVID-19 Infectious titer SARS-CoV-2 Postmortem interval Autopsy Virus isolation |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c517t-d67799cae50f140802ddf5b72cc9039f79612c99d40f67af082c6b5cd1c049f53 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-6297-3738 0000-0001-5636-0695 0000-0002-9250-8420 0000-0001-8852-6530 0000-0003-2270-2313 0000-0003-2258-9031 0000-0003-4891-8673 0000-0003-4513-1007 0000-0002-5332-4434 0000-0003-4172-4892 0000-0002-0025-5252 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1201971223000474 |
PMID | 36754229 |
PQID | 2774896618 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ea332ec2822e438cacfcd58cc4f857f3 proquest_miscellaneous_2774896618 pubmed_primary_36754229 crossref_citationtrail_10_1016_j_ijid_2023_01_046 crossref_primary_10_1016_j_ijid_2023_01_046 elsevier_sciencedirect_doi_10_1016_j_ijid_2023_01_046 elsevier_clinicalkey_doi_10_1016_j_ijid_2023_01_046 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2023 2023-04-00 2023-Apr 20230401 2023-04-01 |
PublicationDateYYYYMMDD | 2023-04-01 |
PublicationDate_xml | – month: 04 year: 2023 text: April 2023 |
PublicationDecade | 2020 |
PublicationPlace | Canada |
PublicationPlace_xml | – name: Canada |
PublicationTitle | International journal of infectious diseases |
PublicationTitleAlternate | Int J Infect Dis |
PublicationYear | 2023 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Shirato, Nao, Katano, Takayama, Saito, Kato (bib0012) 2020; 73 Drommi, Barranco, Balbo, Errico, Elena Frigiolini, Mangioni (bib0001) 2022; 8 Zacharias, Stangl, Thüringer, Loibner, Wurm, Wolfgruber (bib0009) 2021; 27 Heinrich, Meißner, Langenwalder, Püschel, Nörz, Hoffmann (bib0007) 2021; 27 Perchetti, Huang, Peddu, Jerome, Greninger (bib0019) 2020; 58 Fineschi, Aprile, Aquila, Arcangeli, Asmundo, Bacci (bib0016) 2020; 112 Heinrich, Schröder, Gerberding, Gerling, Langenwalder, Lange (bib0010) 2022; 28 Ventura, Drommi, Barranco, Balbo, Errico, Mangioni (bib0002) 2022; 43 Schröder, Edler, Ondruschka, Püschel, Schädler, Heinemann (bib0006) 2021; 17 Grassi, Arena, Cattani, Dell'Aquila, Liotti, Sanguinetti (bib0015) 2022; 136 2022 [accessed 27 September 2022]. Adachi, Chong, Nakajima, Sano, Yamazaki, Miyamoto (bib0011) 2020; 26 Yaacoub, Schünemann, Khabsa, El-Harakeh, Khamis, Chamseddine (bib0017) 2020; 5 2020 [accessed 27 September 2022]. Deinhardt-Emmer, Wittschieber, Sanft, Kleemann, Elschner, Haupt (bib0003) 2021; 10 Plenzig, Bojkova, Held, Berger, Holz, Cinatl (bib0008) 2021; 135 Katano, Kano, Nakamura, Kanno, Asanuma, Sata (bib0013) 2011; 83 Centers for Disease Control and Prevention. Collection and submission of postmortem specimens from deceased persons with confirmed or suspected COVID-19, postmortem guidance Fitzek, Schädler, Dietz, Ron, Gerling, Kammal (bib0004) 2021; 11 World Health Organization. Infection prevention and control for the safe management of a dead body in the context of COVID-19: interim guidance Matsuyama, Nao, Shirato, Kawase, Saito, Takayama (bib0014) 2020; 117 Dijkhuizen, Gelderman, Duijst (bib0020) 2020; 73 Gabbrielli, Gandolfo, Anichini, Candelori, Benvenuti, Savellini (bib0005) 2021; 106 Sablone, Solarino, Ferorelli, Benevento, Chironna, Loconsole (bib0018) 2021; 17 Matsuyama (10.1016/j.ijid.2023.01.046_bib0014) 2020; 117 Fitzek (10.1016/j.ijid.2023.01.046_bib0004) 2021; 11 Zacharias (10.1016/j.ijid.2023.01.046_bib0009) 2021; 27 Adachi (10.1016/j.ijid.2023.01.046_bib0011) 2020; 26 Ventura (10.1016/j.ijid.2023.01.046_bib0002) 2022; 43 Shirato (10.1016/j.ijid.2023.01.046_bib0012) 2020; 73 Katano (10.1016/j.ijid.2023.01.046_bib0013) 2011; 83 Yaacoub (10.1016/j.ijid.2023.01.046_bib0017) 2020; 5 Heinrich (10.1016/j.ijid.2023.01.046_bib0007) 2021; 27 Plenzig (10.1016/j.ijid.2023.01.046_bib0008) 2021; 135 Perchetti (10.1016/j.ijid.2023.01.046_bib0019) 2020; 58 Schröder (10.1016/j.ijid.2023.01.046_bib0006) 2021; 17 Sablone (10.1016/j.ijid.2023.01.046_bib0018) 2021; 17 Drommi (10.1016/j.ijid.2023.01.046_bib0001) 2022; 8 Dijkhuizen (10.1016/j.ijid.2023.01.046_bib0020) 2020; 73 Deinhardt-Emmer (10.1016/j.ijid.2023.01.046_bib0003) 2021; 10 Fineschi (10.1016/j.ijid.2023.01.046_bib0016) 2020; 112 Grassi (10.1016/j.ijid.2023.01.046_bib0015) 2022; 136 10.1016/j.ijid.2023.01.046_bib0022 Gabbrielli (10.1016/j.ijid.2023.01.046_bib0005) 2021; 106 Heinrich (10.1016/j.ijid.2023.01.046_bib0010) 2022; 28 10.1016/j.ijid.2023.01.046_bib0021 |
References_xml | – volume: 10 start-page: e60361 year: 2021 ident: bib0003 article-title: Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage publication-title: eLife – volume: 117 start-page: 7001 year: 2020 end-page: 7003 ident: bib0014 article-title: Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells publication-title: Proc Natl Acad Sci U S A – volume: 83 start-page: 322 year: 2011 end-page: 330 ident: bib0013 article-title: A novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses publication-title: J Med Virol – volume: 136 start-page: 935 year: 2022 end-page: 939 ident: bib0015 article-title: SARS-CoV-2 viral load and replication in postmortem examinations publication-title: Int J Legal Med – volume: 135 start-page: 2055 year: 2021 end-page: 2060 ident: bib0008 article-title: Infectivity of deceased COVID-19 patients publication-title: Int J Legal Med – reference: ; 2022 [accessed 27 September 2022]. – volume: 27 start-page: 329 year: 2021 end-page: 331 ident: bib0007 article-title: Postmortem stability of SARS-CoV-2 in nasopharyngeal mucosa publication-title: Emerg Infect Dis – volume: 58 start-page: e01094 year: 2020 ident: bib0019 article-title: Stability of SARS-CoV-2 in phosphate-buffered saline for molecular detection publication-title: J Clin Microbiol – volume: 5 year: 2020 ident: bib0017 article-title: Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic review publication-title: BMJ Glob Health – volume: 11 start-page: 19342 year: 2021 ident: bib0004 article-title: Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases publication-title: Sci Rep – reference: World Health Organization. Infection prevention and control for the safe management of a dead body in the context of COVID-19: interim guidance, – volume: 106 start-page: 1 year: 2021 end-page: 2 ident: bib0005 article-title: How long can SARS-CoV-2 persist in human corpses? publication-title: Int J Infect Dis – volume: 73 year: 2020 ident: bib0020 article-title: Review: the safe handling of a corpse (suspected) with COVID-19 publication-title: J Forensic Leg Med – volume: 112 start-page: 64 year: 2020 end-page: 77 ident: bib0016 article-title: Management of the corpse with suspect, probable or confirmed COVID-19 respiratory infection - Italian interim recommendations for personnel potentially exposed to material from corpses, including body fluids, in morgue structures and during autopsy practice publication-title: Pathologica – volume: 17 start-page: 411 year: 2021 end-page: 418 ident: bib0006 article-title: The handling of SARS-CoV-2 associated deaths - infectivity of the body publication-title: Forensic Sci Med Pathol – volume: 17 start-page: 403 year: 2021 end-page: 410 ident: bib0018 article-title: Post-mortem persistence of SARS-CoV-2: a preliminary study publication-title: Forensic Sci Med Pathol – volume: 43 start-page: 215 year: 2022 end-page: 219 ident: bib0002 article-title: How Long Can a dead body remain infectious?: postmortem nasopharyngeal swabs and SARS-CoV-2 culture in a corpse over an 87-day period publication-title: Am J Forensic Med Pathol – volume: 28 start-page: 244 year: 2022 end-page: 247 ident: bib0010 article-title: Postmortem antigen-detecting rapid diagnostic tests to predict infectivity of SARS-CoV-2-Associated deaths publication-title: Emerg Infect Dis – volume: 8 start-page: 24 year: 2022 end-page: 31 ident: bib0001 article-title: Postmortem nasopharyngeal swabs performed during the COVID-19 infection: analysis of preliminary clinical records by the Genoa institute of legal medicine (North-West Italy) publication-title: J Forensic Sci Med – volume: 73 start-page: 304 year: 2020 end-page: 307 ident: bib0012 article-title: Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan publication-title: Jpn J Infect Dis – reference: Centers for Disease Control and Prevention. Collection and submission of postmortem specimens from deceased persons with confirmed or suspected COVID-19, postmortem guidance, – volume: 27 start-page: 1734 year: 2021 end-page: 1737 ident: bib0009 article-title: Rapid antigen test for postmortem evaluation of SARS-CoV-2 carriage publication-title: Emerg Infect Dis – volume: 26 start-page: 2157 year: 2020 end-page: 2161 ident: bib0011 article-title: Clinicopathologic and immunohistochemical findings from autopsy of patient with COVID-19 publication-title: Japan. Emerg Infect Dis – reference: ; 2020 [accessed 27 September 2022]. – volume: 17 start-page: 411 year: 2021 ident: 10.1016/j.ijid.2023.01.046_bib0006 article-title: The handling of SARS-CoV-2 associated deaths - infectivity of the body publication-title: Forensic Sci Med Pathol doi: 10.1007/s12024-021-00379-9 – volume: 58 start-page: e01094 year: 2020 ident: 10.1016/j.ijid.2023.01.046_bib0019 article-title: Stability of SARS-CoV-2 in phosphate-buffered saline for molecular detection publication-title: J Clin Microbiol doi: 10.1128/JCM.01094-20 – volume: 27 start-page: 329 year: 2021 ident: 10.1016/j.ijid.2023.01.046_bib0007 article-title: Postmortem stability of SARS-CoV-2 in nasopharyngeal mucosa publication-title: Emerg Infect Dis doi: 10.3201/eid2701.203112 – volume: 27 start-page: 1734 year: 2021 ident: 10.1016/j.ijid.2023.01.046_bib0009 article-title: Rapid antigen test for postmortem evaluation of SARS-CoV-2 carriage publication-title: Emerg Infect Dis doi: 10.3201/eid2706.210226 – volume: 28 start-page: 244 year: 2022 ident: 10.1016/j.ijid.2023.01.046_bib0010 article-title: Postmortem antigen-detecting rapid diagnostic tests to predict infectivity of SARS-CoV-2-Associated deaths publication-title: Emerg Infect Dis doi: 10.3201/eid2801.211749 – volume: 11 start-page: 19342 year: 2021 ident: 10.1016/j.ijid.2023.01.046_bib0004 article-title: Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases publication-title: Sci Rep doi: 10.1038/s41598-021-98499-3 – volume: 73 year: 2020 ident: 10.1016/j.ijid.2023.01.046_bib0020 article-title: Review: the safe handling of a corpse (suspected) with COVID-19 publication-title: J Forensic Leg Med doi: 10.1016/j.jflm.2020.101999 – volume: 112 start-page: 64 year: 2020 ident: 10.1016/j.ijid.2023.01.046_bib0016 publication-title: Pathologica – ident: 10.1016/j.ijid.2023.01.046_bib0021 – volume: 43 start-page: 215 year: 2022 ident: 10.1016/j.ijid.2023.01.046_bib0002 article-title: How Long Can a dead body remain infectious?: postmortem nasopharyngeal swabs and SARS-CoV-2 culture in a corpse over an 87-day period publication-title: Am J Forensic Med Pathol doi: 10.1097/PAF.0000000000000779 – volume: 106 start-page: 1 year: 2021 ident: 10.1016/j.ijid.2023.01.046_bib0005 article-title: How long can SARS-CoV-2 persist in human corpses? publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2021.03.052 – ident: 10.1016/j.ijid.2023.01.046_bib0022 – volume: 73 start-page: 304 year: 2020 ident: 10.1016/j.ijid.2023.01.046_bib0012 article-title: Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan publication-title: Jpn J Infect Dis doi: 10.7883/yoken.JJID.2020.061 – volume: 5 year: 2020 ident: 10.1016/j.ijid.2023.01.046_bib0017 article-title: Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic review publication-title: BMJ Glob Health doi: 10.1136/bmjgh-2020-002650 – volume: 135 start-page: 2055 year: 2021 ident: 10.1016/j.ijid.2023.01.046_bib0008 article-title: Infectivity of deceased COVID-19 patients publication-title: Int J Legal Med doi: 10.1007/s00414-021-02546-7 – volume: 17 start-page: 403 year: 2021 ident: 10.1016/j.ijid.2023.01.046_bib0018 article-title: Post-mortem persistence of SARS-CoV-2: a preliminary study publication-title: Forensic Sci Med Pathol doi: 10.1007/s12024-021-00375-z – volume: 26 start-page: 2157 year: 2020 ident: 10.1016/j.ijid.2023.01.046_bib0011 article-title: Clinicopathologic and immunohistochemical findings from autopsy of patient with COVID-19 publication-title: Japan. Emerg Infect Dis doi: 10.3201/eid2609.201353 – volume: 8 start-page: 24 year: 2022 ident: 10.1016/j.ijid.2023.01.046_bib0001 article-title: Postmortem nasopharyngeal swabs performed during the COVID-19 infection: analysis of preliminary clinical records by the Genoa institute of legal medicine (North-West Italy) publication-title: J Forensic Sci Med doi: 10.4103/jfsm.jfsm_5_21 – volume: 83 start-page: 322 year: 2011 ident: 10.1016/j.ijid.2023.01.046_bib0013 article-title: A novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses publication-title: J Med Virol doi: 10.1002/jmv.21962 – volume: 117 start-page: 7001 year: 2020 ident: 10.1016/j.ijid.2023.01.046_bib0014 article-title: Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.2002589117 – volume: 136 start-page: 935 year: 2022 ident: 10.1016/j.ijid.2023.01.046_bib0015 article-title: SARS-CoV-2 viral load and replication in postmortem examinations publication-title: Int J Legal Med doi: 10.1007/s00414-021-02753-2 – volume: 10 start-page: e60361 year: 2021 ident: 10.1016/j.ijid.2023.01.046_bib0003 article-title: Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage publication-title: eLife doi: 10.7554/eLife.60361 |
SSID | ssj0004668 |
Score | 2.3753102 |
Snippet | •Infectious SARS-CoV-2 remained in 55% (6/11) corpses and 43% (13/30) specimens.•The highest infectious titer was 2.09E + 06 plaque-forming units/g in corpse... The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not been... Objectives: The prolonged presence of infectious SARS-CoV-2 in deceased patients with COVID-19 has been reported. However, infectious virus titers have not... |
SourceID | doaj proquest pubmed crossref elsevier |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 103 |
SubjectTerms | Autopsy Cadaver Communicable Diseases COVID-19 COVID-19 - diagnosis COVID-19 Testing Humans Infectious titer Lung Postmortem interval SARS-CoV-2 Virus isolation |
SummonAdditionalLinks | – databaseName: DOAJ: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh1IIpd226TZpUaG3IrD1sKxjsm3YFNJC8yA3YY8k2BB2l-zm_2fGsk1yaHLp1Ui2NBp5vhnNfGLsG2LWKBsdhG4UOihVY0WjqBDYhdaE2skqUmjg9Hc1v9C_rszVg6u-KCcs0wNnwVGUV8kIlO0YtaqhgQTB1AA61camjucTbd7gTI0VkbkIDs2bcLaUfblMzuxaXC-II1SqjrCToO8Dk9Qx9z-yTP9Cnp0FOn7DXvfQkR_mIb9lL-Jywl6e9ofjE7abQ3A8Vxa9YyeUw8E73uQNXyU-5F3dbfjZ4d8zMVtdColPOTqg603s2vQ0qxtO8Vk--3N58kOU7j27OP55PpuL_uYEAaa0WxEqa52DJpoioQdVFzKEZForAVyhXLIOgQ04F3SRKtskxAFQtQZCCegxJKM-sJ3lahk_Mu5MSLqMsjIJdDS1syj-UOvQFrgW4KasHITnoacVp9stbvyQP3btSeCeBO6L0qPAp-z72GedSTWebH1EazK2JELs7gGqie_VxD-nJlOmhhX1Q80p_iXxRYsnP23GXj0iyUjj2X5fB6XxuF3pDKZZRlxfLy3R_SAoqqdsL2vTODFV0XXE0n36HxPeZ69oQDnJ6IDtbG_v4mfET9v2S7dV7gHWYROH priority: 102 providerName: Directory of Open Access Journals |
Title | High titers of infectious SARS-CoV-2 in corpses of patients with COVID-19 |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1201971223000474 https://dx.doi.org/10.1016/j.ijid.2023.01.046 https://www.ncbi.nlm.nih.gov/pubmed/36754229 https://www.proquest.com/docview/2774896618 https://doaj.org/article/ea332ec2822e438cacfcd58cc4f857f3 |
Volume | 129 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhh1IoJU1f27RBhd6Ku7YelnVMNg3ZlrTQbcLehKxHcCi7S3Zz7W_vjCUvyaEp9GKwGNnyaKz5JM18IuQDYNbArPCFsBwmKLVVheWYCKx9K32jWR1waeD8W312Ib7M5XyHTIZcGAyrzGN_GtP70TqXjLM2x6uuG88q8F1aVeDfEJgo5AQVQqGVf_pd3cmNTOlwIFygdE6cSTFe3XWHbKGM99SdCILvOKeew_-ej_obBu190ekeeZpBJD1K7XxGdsJinzw6z9vk--RJWoyjKcfoOZliNAftGZTXdBnpEIF1u6azox-zYrK8LBiUUpiKrtahl8mEq2uKK7V08v1yelJU-gW5OP38c3JW5DMUCicrtSl8rZTWzgZZRphLNSXzPspWMed0yXVUGiCO09qLMtbKRkAErm6l85WDuUOU_CXZXSwX4TWhWvooqsBqGZ0IstHKeehO4dvSWXjciFSD8ozLBON4zsUvM0SSXRtUuEGFm7IyoPAR-bits0r0Gg9KH2OfbCWRGrsvWN5cmWwbJljOWXAYHhsEb6BpEdrZOCdiI1XkI8KHHjVD9imMl_Cg7sFXy22te_b5z3rvB6Mx8OPiboxdBOhfwxQS_wA8akbkVbKm7YfxGg8mZvrNf771gDzGuxRh9Jbsbm5uwzsAT5v2sP874Hoy_XrYL0DAdTo__gMoTBV7 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtNAdFQVCZAQgrKlbIMEJ2Riz-LxHDiUlCqhTZFIW_U2tWdBrqokalIhLvwUP8h79jhqDxQJqdfxbH7vzVtm3kLIW9BZPSuFS0TJwUDJS5WUHAOBtaukKzTLPV4NjPfz4aH4ciyP18jvLhYG3Soj7295esOtY0s_QrM_r-v-JAPZpVUG8g0VEyWiZ-Wu__kD7LbFx9E2IPkdYzufDwbDJJYWSKzM1DJxuVJa29LLNICJUaTMuSArxazVKddBaZD8Vmsn0pCrMoCgtHklrcssqNQBS0UA378lgF1g2YQPv7JLwZht_B3sLsHtxUid1qmsPq0xPSnjTa5Q1LovScOmaMAVofg3pbcRfjsPyP2otdKtFjAPyZqfbpDb4_guv0Hutbd_tA1qekRG6D5Cm5TNCzoLtHP5uljQyda3STKYHSUMWinYvvOFb_rEDK8LilfDdPD1aLSdZPoxObwRyD4h69PZ1D8jVEsXROZZLoMVXhZaWQf0I1yV2hKm65GsA56xMaM5FtY4M53r2qlBgBsEuEkzAwDvkferMfM2n8e1vT8hTlY9MRd30zA7_24iMRpfcs68RX9cL3gBWwuwz8JaEQqpAu8R3mHUdOGuwKBhovrapeVq1JUD8c9xbzqiMcAp8PmnnHrAr2EKMw2BPlb0yNOWmlY_xnOshMz05n-u-prcGR6M98zeaH_3ObmLX1r3phdkfXl-4V-C5rasXjUnhZKTmz6afwDFsk9H |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+titers+of+infectious+SARS-CoV-2+in+corpses+of+patients+with+COVID-19&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Saitoh%2C+Hisako&rft.au=Sakai-Tagawa%2C+Yuko&rft.au=Nagasawa%2C+Sayaka&rft.au=Torimitsu%2C+Suguru&rft.date=2023-04-01&rft.pub=Elsevier+Ltd&rft.issn=1201-9712&rft.eissn=1878-3511&rft.volume=129&rft.spage=103&rft.epage=109&rft_id=info:doi/10.1016%2Fj.ijid.2023.01.046&rft.externalDocID=S1201971223000474 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon |